Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verbist

Showing results (171-180 of 588) with videos related to

Pageof 59
Sort By:
Cell Calcium|June 1, 1984
Reconstitution of the purified calmodulin-dependent (Ca2+ + Mg2+)-ATPase from smooth muscleJ Verbist, F Wuytack, G De Schutter, et al.
Acta Tuberculosea Et Pneumologica Belgica|July 1, 1971
Five years of clinical experience with rifampicinA Gyselen, J Cosemans, L M Lacquet, et al.
Biochimica Et Biophysica Acta|May 29, 1987
Smooth-muscle endoplasmic reticulum contains a cardiac-like form of calsequestrinF Wuytack, L Raeymaekers, J Verbist, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1987
Norfloxacin versus thiamphenicol for treatment of uncomplicated gonorrhea in RwandaJ Bogaerts, W Martinez Tello, L Verbist, et al.
Planta Medica|October 1, 1994
Cytotoxic activity of xanthatin and the crude extracts of Xanthium strumariumC Roussakis, I Chinou, C Vayas, et al.
Vascular|July 6, 2005
Selection of treatment for patients with carotid artery disease: medication, carotid endarterectomy, or carotid artery stentingMarc Bosiers, Patrick Peeters, Koen Deloose, et al.
Hepato-Gastroenterology|November 14, 1997
Cystadenocarcinoma of the pancreas: characteristics and surgical strategyP Brewaeys, R Van Hee, D Ysebaert, et al.
Arzneimittel-Forschung|January 1, 1979
Mezlocillin pharmacokinetics. Comparison with ampicillin and influence of probenecidL Verbist, T B Tjandramaga, R Verbesselt, et al.
La Nouvelle Presse Medicale|February 4, 1982
[Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)]L Verbist, T B Tjandramaga, R Verbesselt, et al.
Revue Medicale Suisse|June 29, 2007
[New treatments for renal cell carcinoma: hope and limits]A Bodner, M F Pelte, M C Verbist, et al.
Pageof 59

Showing results (171-180 of 588) with videos related to

Sort By:
Pageof 59
Cell Calcium|June 1, 1984
Reconstitution of the purified calmodulin-dependent (Ca2+ + Mg2+)-ATPase from smooth muscleJ Verbist, F Wuytack, G De Schutter, et al.
Acta Tuberculosea Et Pneumologica Belgica|July 1, 1971
Five years of clinical experience with rifampicinA Gyselen, J Cosemans, L M Lacquet, et al.
Biochimica Et Biophysica Acta|May 29, 1987
Smooth-muscle endoplasmic reticulum contains a cardiac-like form of calsequestrinF Wuytack, L Raeymaekers, J Verbist, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1987
Norfloxacin versus thiamphenicol for treatment of uncomplicated gonorrhea in RwandaJ Bogaerts, W Martinez Tello, L Verbist, et al.
Planta Medica|October 1, 1994
Cytotoxic activity of xanthatin and the crude extracts of Xanthium strumariumC Roussakis, I Chinou, C Vayas, et al.
Vascular|July 6, 2005
Selection of treatment for patients with carotid artery disease: medication, carotid endarterectomy, or carotid artery stentingMarc Bosiers, Patrick Peeters, Koen Deloose, et al.
Hepato-Gastroenterology|November 14, 1997
Cystadenocarcinoma of the pancreas: characteristics and surgical strategyP Brewaeys, R Van Hee, D Ysebaert, et al.
Arzneimittel-Forschung|January 1, 1979
Mezlocillin pharmacokinetics. Comparison with ampicillin and influence of probenecidL Verbist, T B Tjandramaga, R Verbesselt, et al.
La Nouvelle Presse Medicale|February 4, 1982
[Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)]L Verbist, T B Tjandramaga, R Verbesselt, et al.
Revue Medicale Suisse|June 29, 2007
[New treatments for renal cell carcinoma: hope and limits]A Bodner, M F Pelte, M C Verbist, et al.
Pageof 59